paclitaxel combined with platinum for uterine cervical neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Jul 2022: Trial started, NCT05735145
  2. 21 Feb 2023: Trial registered, NCT05735145

The trials

NCT05735145: Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer

State
Under way
Phase
Phase 3
People
108 planned
Started
1 Jul 2022
Primary completion
30 Jun 2025
Arms
concurrent chemoradiotherapy combined with adjuvant chemotherapy
Results
None posted
  1. 1 Jul 2022: Trial started
  2. 21 Feb 2023: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.